摘要 |
<p>The present invention relates to a graft material derived from mammalian cartilage. The graft material according to the present invention has significantly lowered risk by eliminating antigenicity, pathogen and cytotoxicity through multi-step processing treatments and inactivating all kinds of pathogens without affecting biomechanics and tissue reconstruction performance. It allows smooth accepting and supplying and low cost manufacturing because of use of mammalian cartilage not human's.</p> |